K1 Ketones: What My Patients Actually Said After 10 Days

Why I Ran This With Patients

I have been recommending exogenous ketones in clinical practice since 2020. I know what BHB does and I know its limits. Sometimes the 60 to 90 minute window, the peak and the drop. The patients who love it and the patients who find it jittery and then flat.

When K1 launched with a dual-substrate formula, combining BHB with C5 ketones, I was curious about one specific question: does the C5 component actually change the clinical experience, or is this just reformulation marketing?

The only way to answer that honestly was to run it with real patients, track real responses, and report what actually happened. So that is what I did.

Ten to fifteen patients. Ten days. Three markers tracked daily: hunger, mental clarity, and energy duration. And whatever else came up organically in our check-ins, which turned out to be the most interesting data of all.

What Came Back:  The Consistent Patterns

Across the group, four things appeared consistently enough that I now consider them reliable clinical observations rather than individual responses.

1. The flavour surprised everyone

This sounds trivial. It is not.

Previous BHB ketone products, including Pruvit’s earlier formulas, had a flavour that many patients described as difficult to get through. Some tolerated it fine. Others never quite adjusted. It was a compliance issue. People who do not enjoy drinking something do not drink it consistently, and inconsistency kills results.

K1 uses allulose as its sweetener instead of erythritol. The difference in palatability is significant. Across my patient group, every single person commented on the taste without being prompted. The word that came up most often was “clean.” Not sweet in a fake way. Not chalky. Clean.

One patient who had stopped using NAT specifically because of the taste finished all 10 days of K1 without a single complaint about flavour.

Compliance went up. When compliance goes up, results go up. This is not a small thing.

2. The energy lasted longer than anything they had used before

This was the most medically significant finding and the one that confirmed what the C5 physiology predicted.

Standard BHB products produce a ketone peak that most experienced users can feel for roughly 60 to 120 minutes. After that, the energy begins to taper. It does not crash dramatically but it softens noticeably.

K1 patients consistently described the effective window as four hours or longer. Not a plateau that suddenly dropped but a gradual, comfortable extension that carried through the morning without a clear end point.

The most common version of this I heard was some variation of “I looked at the clock and it was noon and I had not thought about food since 7am.”

That is not nothing. For patients who have been fasting for years and still find the late morning difficult, that shift in experience is clinically meaningful.

3. Appetite suppression was stronger and more sustained

Hunger during a fasting window is the primary reason people break their fast early. Managing hunger is managing compliance. Managing compliance is managing results.

What patients described with K1 was not the absence of hunger, which would be neither realistic nor desirable. It was a different quality of hunger. Less urgent. Less insistent. One patient put it this way: “I know I am hungry but I do not feel like I need to do something about it immediately.”

That distinction, hunger without urgency, is exactly what allows someone to extend a fasting window comfortably. It is also consistent with what we know about ketones and ghrelin suppression, but the duration of the effect with K1 was longer than what I have observed with BHB-only formulas.

4. The cognitive quality was the unexpected star

I expected energy. I expected reduced hunger. I did not expect the consistency with which patients described a specific quality of mental state that went beyond focus.

This is where the “GLP-1 and Xanax baby” description becomes relevant. What that patient was pointing at, inarticulately but accurately, was a combination of two things happening simultaneously.

First, appetite and impulse felt quieter. Not suppressed in a sedated way. Just less loud. The background noise of cravings, food thoughts, and the low-level anxiety of hunger that most chronic dieters carry around all day, that noise turned down.

Second, decision making felt more deliberate and less reactive. Several patients mentioned making better food choices inside their eating window without consciously trying harder. One described it as “choosing the salad and actually wanting the salad.” Another said her afternoon work was sharper because she was not distracted by thinking about what she was going to eat.

This combination, quieter impulse plus clearer cognition, is what produced the “assertive calm” description. It is not sedation. It is not stimulation. It is something in between that the English language does not have a great single word for.

Clinically, I believe this is what optimal metabolic function feels like. Most of us have simply never experienced it consistently enough to recognise it.

The One Person Who Did Not Respond Well

Honest reporting requires including this.

One patient in the group experienced jitteriness and elevated heart rate on day 1 at the full sachet dose. But, she had two large coffees before taking K1.

Her existing caffeine load was too much for her system. We reduced her second coffee, and the symptoms resolved by day 2. She completed the 10 days with no further issues and reported the same positive patterns as the rest of the group from day 3 onwards.

The lesson is not that K1 caused a problem. The lesson is that K1 contains caffeine and needs to be treated as part of your total daily caffeine intake, not added on top of it.